Purity 98%: Growth Hormone Releasing Peptide-6 (Ghrp-6) with purity 98% is used in peptide therapy formulation, where it ensures consistent bioactivity and enhanced receptor affinity.

Molecular weight 873.01 Da: Growth Hormone Releasing Peptide-6 (Ghrp-6) with molecular weight 873.01 Da is used in injectable preparations, where it allows predictable pharmacokinetics and efficient absorption.

Lyophilized powder form: Growth Hormone Releasing Peptide-6 (Ghrp-6) in lyophilized powder form is used in clinical research protocols, where it provides improved shelf stability and facilitates precise dosing.

Stability at 2-8°C: Growth Hormone Releasing Peptide-6 (Ghrp-6) stable at 2-8°C is used in pharmaceutical storage, where it maintains peptide integrity and minimizes degradation during transport.

Endotoxin level <0.1 EU/mg: Growth Hormone Releasing Peptide-6 (Ghrp-6) with endotoxin level <0.1 EU/mg is used in sterile injectable formulations, where it reduces the risk of pyrogenic response in preclinical studies.

Peptide sequence H-His-D-Trp-Ala-Trp-D-Phe-Lys-NH2: Growth Hormone Releasing Peptide-6 (Ghrp-6) with peptide sequence H-His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 is used in receptor binding assays, where it demonstrates selective agonism of ghrelin receptors.

Solubility >10 mg/mL in water: Growth Hormone Releasing Peptide-6 (Ghrp-6) with solubility >10 mg/mL in water is used in laboratory solution preparations, where it supports rapid and complete dissolution for experimental use.

pH stability range 4.0-8.0: Growth Hormone Releasing Peptide-6 (Ghrp-6) stable in the pH range 4.0-8.0 is used in formulation design, where it maintains functional conformation in various physiological conditions.

Residual solvent <0.5%: Growth Hormone Releasing Peptide-6 (Ghrp-6) with residual solvent <0.5% is used in GMP-compliant manufacturing, where it ensures product safety and regulatory compliance.

Single impurity <1%: Growth Hormone Releasing Peptide-6 (Ghrp-6) with single impurity content <1% is used in chronic administration studies, where it supports reproducible therapeutic efficacy and minimal side effects.